Anesth Pain Med.  2023 Jan;18(1):92-96. 10.17085/apm.22236.

Severe pancytopenia and coagulopathy discovered during anesthesia after pre-anesthetic evaluation – A report of two cases –

• Heo HJ
• Kim YY
• Lee JH
• Cho HG
• Kim G

• KMID: 2540340
• DOI: http://doi.org/10.17085/apm.22236

Abstract

Background
Pre-anesthetic evaluation is an important aspect of perioperative patient management. However, anesthesiologists often encounter challenges during anesthesia due toconditions that are not detected during pre-anesthetic evaluations.Case: Case 1 involved a 74-year-old female patient scheduled for cranioplasty and meningioma excision. Severe pancytopenia was detected during anesthesia. Cranioplasty was onlyperformed, the surgery was terminated, and drug-induced pancytopenia was diagnosed andtreated. The pre-anesthetic test results were normal, except for anemia. Case 2 involved a71-year-old male patient who discovered large ecchymosis during general anesthesia preparation in the operating room for choledochal cyst surgery. Surgery was canceled to evaluatethe bleeding tendency, and acquired coagulation factor VIII deficiency was diagnosed andtreated. The pre-anesthetic tests were normal, except for prolongation of the activated partial thromboplastin time.Conclusions: Abrupt hematologic and hemostatic changes may occur during anesthesiaeven though pre-anesthetic evaluation findings are normal.

Keyword

Anesthesia; Coagulation; Coagulation factor deficiency; Pancytopenia; Pre-anesthetic evaluation

Reference

1. Apfelbaum JL, Connis RT, Nickinovich DG, Pasternak LR, Arens JF, Caplan RA, et al. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology. 2012; 116:522–38.

2. De Hert S, Staender S, Fritsch G, Hinkelbein J, Afshari A, Bettelli G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018; 35:407–65.

3. O'Neill F, Carter E, Pink N, Smith I. Routine preoperative tests for elective surgery: summary of updated NICE guidance. BMJ. 2016; 354:i3292.

4. Alzahrani T, Kay D, Alqahtani SA, Makke Y, Lesky L, Koubeissi MZ. Levetiracetam-induced pancytopenia. Epilepsy Behav Case Rep. 2015; 4:45–7.

5. Cho JN, Avera S, Iyamu K. Pancytopenia as a consequence of sepsis and intravenous antibiotic drug toxicity. Cureus. 2019; 11:e3994.

6. Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Transfusion. 2004; 44:1033–40.

7. Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009; 2009:495863.

8. Amaeshi LC, Santiago C, Vaughn RD, Ogamba CF, Sucu AS. Levetiracetam-induced pancytopenia in an HIV seropositive patient with SARS-CoV-2. Ann Intern Med Clin Cases. 2022; 1:e220115.

9. Piedra Abusharar S, Shah N, Patel R, Jain R, Polimera HV. A case of confirmed ceftriaxone-induced immune thrombocytopenia. Cureus. 2019; 11:e4688.

10. Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017; 6:8.